ClariVest Asset Management LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q4 2022$454
-99.9%
89,642
-0.3%
0.02%0.0%
Q3 2022$447,000
+33.4%
89,908
-0.3%
0.02%
+46.7%
Q2 2022$335,000
+10.9%
90,151
+67.8%
0.02%
+25.0%
Q1 2022$302,000
+27.4%
53,727
+37.5%
0.01%
+71.4%
Q4 2021$237,000
-88.2%
39,061
-81.1%
0.01%
-89.2%
Q3 2021$2,010,000
-35.0%
206,332
-4.7%
0.06%
-36.9%
Q2 2021$3,090,000216,4250.10%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 335,709$933,2710.26%
ALLEN HOLDING INC /NY 687,571$1,911,4470.26%
Clearwater Capital Advisors, LLC 394,599$1,096,9860.13%
SHEETS SMITH WEALTH MANAGEMENT 269,129$748,1790.11%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$268,0840.10%
WEALTH EFFECTS LLC 71,000$197,3800.09%
Virtus ETF Advisers LLC 37,888$105,3290.06%
DARK FOREST CAPITAL MANAGEMENT LP 203,659$566,1720.05%
Bell & Brown Wealth Advisors, LLC 20,100$55,8780.03%
FISHMAN JAY A LTD/MI 162,000$450,3600.03%
View complete list of IMMUNITYBIO INC shareholders